熱門資訊> 正文

ADC Therapeutics第三季度盈利预览

2025-11-08 01:01

ADC Therapeutics (ADCT) is scheduled to announce Q3 earnings results on Monday, November 10th, before market open.
The consensus EPS Estimate is -$0.36 (-28.6% Y/Y) and the consensus Revenue Estimate is $16.79M (-9.0% Y/Y).
Over the last 2 years, ADCT has beaten EPS estimates 0% of the time and has beaten revenue estimates 38% of the time.

More on ADC Therapeutics

ADC Therapeutics SA 2025 Q2 - Results - Earnings Call Presentation
ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Transcript
ADC Therapeutics rises on $60M PIPE financing
ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts
Seeking Alpha’s Quant Rating on ADC Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。